全文获取类型
收费全文 | 164679篇 |
免费 | 15866篇 |
国内免费 | 7606篇 |
专业分类
耳鼻咽喉 | 2283篇 |
儿科学 | 3736篇 |
妇产科学 | 1816篇 |
基础医学 | 30111篇 |
口腔科学 | 5332篇 |
临床医学 | 12664篇 |
内科学 | 22490篇 |
皮肤病学 | 4429篇 |
神经病学 | 9136篇 |
特种医学 | 3633篇 |
外国民族医学 | 118篇 |
外科学 | 14348篇 |
综合类 | 25787篇 |
现状与发展 | 49篇 |
预防医学 | 4310篇 |
眼科学 | 3466篇 |
药学 | 12773篇 |
26篇 | |
中国医学 | 5090篇 |
肿瘤学 | 26554篇 |
出版年
2024年 | 134篇 |
2023年 | 2308篇 |
2022年 | 2921篇 |
2021年 | 5614篇 |
2020年 | 5334篇 |
2019年 | 5195篇 |
2018年 | 5380篇 |
2017年 | 5702篇 |
2016年 | 5961篇 |
2015年 | 6809篇 |
2014年 | 9887篇 |
2013年 | 10936篇 |
2012年 | 9505篇 |
2011年 | 10659篇 |
2010年 | 8833篇 |
2009年 | 8495篇 |
2008年 | 8941篇 |
2007年 | 9155篇 |
2006年 | 8335篇 |
2005年 | 7660篇 |
2004年 | 6779篇 |
2003年 | 5863篇 |
2002年 | 4812篇 |
2001年 | 4120篇 |
2000年 | 3398篇 |
1999年 | 2957篇 |
1998年 | 2427篇 |
1997年 | 2367篇 |
1996年 | 2048篇 |
1995年 | 2070篇 |
1994年 | 1830篇 |
1993年 | 1525篇 |
1992年 | 1233篇 |
1991年 | 1170篇 |
1990年 | 897篇 |
1989年 | 846篇 |
1988年 | 787篇 |
1987年 | 626篇 |
1986年 | 586篇 |
1985年 | 777篇 |
1984年 | 689篇 |
1983年 | 483篇 |
1982年 | 508篇 |
1981年 | 403篇 |
1980年 | 341篇 |
1979年 | 254篇 |
1978年 | 178篇 |
1977年 | 138篇 |
1976年 | 103篇 |
1975年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
991.
992.
993.
《International journal of oral and maxillofacial surgery》2022,51(8):981-986
The feasibility of submandibular gland (SMG) preservation during neck dissection has been described. The aim of this study was to analyse the functional outcomes in patients undergoing SMG preservation during neck dissection for cT1–2N0 oral squamous cell carcinoma. Consecutive patients were divided into two groups based on the management of the SMG, and underwent a saliva flow test before surgery, 7 days after surgery, and at 3, 6, 9, and 12 months after surgery. All enrolled patients completed the fourth version of the University of Washington Quality of Life (UWQOL) questionnaire at 12 months after surgery. In patients who underwent SMG preservation during neck dissection, the flow rate at 7 days after surgery was significantly lower than that preoperative; however, it gradually returned to baseline at 9 months after surgery. The saliva flow rate at 9 months after surgery was similar to that at 12 months after surgery. Further, patients with SMG preservation had higher scores for the activity, swallowing, chewing, and saliva domains than patients without SMG preservation. The results of the study suggest that saliva secretion ability can be preserved following SMG-sparing neck dissection, and that SMG preservation improves postoperative quality of life. 相似文献
994.
995.
岳银艳 《国际生物制品学杂志》2022,45(2):116-120
支气管肺发育不良(broncho-pulmonary dysplasia,BPD)是早产儿最常见的并发症之一,也是影响早产儿预后的重要因素。然而目前临床对BPD的治疗方法有限且疗效不佳,寻找BPD新的防治方案迫在眉睫。近些年,基础实验及临床研究均发现间充质干细胞移植对BPD有一定疗效,极可能成为治疗BPD新的有效手段。此文从基础和临床研究两个层面总结间充质干细胞对BPD防治作用,并对其远景进行展望。 相似文献
996.
目的:探讨赣南地区原发性肺鳞癌患者EGFR和ALK基因突变的特点,科学指导此类患者优选靶向用药。方法:入组73例原发性肺鳞癌病例,采用ARMS-PNA技术检测EGFR基因第18、19、20、21外显子突变,应用不平衡法检测其中60例病例的ALK融合基因,回顾性分析EGFR和ALK基因突变患者的临床病理特征。结果:EGFR基因突变8例,阳性率为10.96%(8/73),4例为L858R突变,3例为19del突变,1例为G719X突变。女性患者突变率(66.67%,2/3)明显高于男性患者(8.57%,6/70)(P=0.030),EGFR基因突变在高龄(≥60岁)、进展期(N_(1-3)、Ⅲ+Ⅳ期)患者中相对较高,但差异无统计学意义(P>0.05)。EGFR基因突变与吸烟史、T分期以及肿瘤分布位置均无相关性(P>0.05);ALK融合基因表达2例,阳性率3.33%(2/60),与患者性别、年龄、吸烟史、TNM分期及肿瘤分布类型等各临床病理特征均无相关性(P>0.05);未发现EGFR和ALK基因共存突变病例。结论:赣南地区原发性肺鳞癌患者EGFR和ALK基因突变率相对不高,EGFR基因突变以L858R和19del突变为主,且好发于女性患者,可能是患者病情进展的预测因子之一。 相似文献
997.
998.
What is the Potential Interplay between Microbiome and Tumor Microenvironment in Oral Squamous Cell Carcinomas? 下载免费PDF全文
Chen-Xi Li Hui Liu Zhong-Cheng Gong 《Asian Pacific journal of cancer prevention》2022,23(7):2199-2213
Oral cancer, with an around 50% mortality rate, is one of the most common malignancies world-wide. It is often detected in advanced or terminal stage and has a poor prognosis, although substantial progress in cancer management. Microbiome has become an increasingly recognized factor that may contribute to the cancerous development. Oral microbiological population comprising more than 700 bacterial species, varies since saliva and different habitats of oral cavity. A shift of composition of oral microbiome from usual condition to functional inflammation to pathological state has been discovered amongst patients with premalignant disorders and oral carcinoma, with evidence suggesting the tumor microenvironment (TME) could strongly exacerbate the influence of oral microorganisms. The complex interactions taking place in either cancer formation or progression have been evaluated in several publications, however given their results’ heterogeneity, a review is needed to correctly untangle the potential correlation in this group of pro-carcinogenesis. In this review, we briefly summarize our current knowledge of the role of oral microbiome, focusing on its potential crosstalk with TME in oral squamous cell carcinomas (OSCC) more precisely, and pave the way for manipulating oral microbiome to deal with OSCC in the future. 相似文献
999.
1000.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2022,34(8):e345-e352
AimsPoor growth in childhood cancer survivors who undergo haematopoietic stem cell transplant (HSCT) without exposure to radiation is reported anecdotally, although literature to support this is limited. The aims of this study were to assess the change in height standard deviation score (SDS) and the final adult height (FAH) in children who underwent chemotherapy-only conditioned HSCT and to identify predictors of poor growth.Materials and methodsWe conducted a retrospective hospital medical record review (1984–2010) of children (1–10 years) who underwent chemotherapy-only conditioned HSCT, noting anthropology measurements at cancer diagnosis, HSCT, 10 years old and FAH.ResultsThe median age at HSCT of the 53 patients was 4.5 years, 75% had a haematological malignancy and 25% a solid tumour. Half of the cohort underwent allogenic HSCT and most (89%) conditioned with busulphan. The mean change in height SDS from primary cancer diagnosis to FAH was –1.21 (±1.18 SD), equivalent to 7–8.5 cm loss, with a mean FAH of –0.91 SDS (±1.10 SD). The greatest height loss occurred between diagnosis and HSCT (–0.77 SDS, 95% confidence interval –1.42, –0.12, P = 0.01), with no catch-up growth seen by FAH. Patients with solid tumours had the greatest height loss. Overall body mass index SDS did not change significantly over time, or by cancer type.ConclusionsChemotherapy-only conditioned HSCT during childhood can impact FAH, with the greatest height loss occurring prior to HSCT and no catch-up growth after treatment finishes. Children transplanted for a solid tumour malignancy seem to be more at risk, possibly due to intensive treatment regimens, both pre-transplant and during conditioning. 相似文献